When sourcing follistatin peptide kopen for institutional or laboratory research, procurement teams require analytical verification of sequence integrity, isoform clarity, and minimal endotoxin burden. Follistatin compounds supplied by PX1 Research are manufactured in US-based, GMP-compliant facilities and undergo rigorous third-party mass spectrometry and HPLC purity validation strictly for in vitro and preclinical investigation.
When sourcing follistatin peptide kopen for institutional or laboratory research, procurement teams require analytical verification of sequence integrity, isoform clarity, and minimal endotoxin burden. Follistatin compounds supplied by PX1 Research are manufactured in US-based, GMP-compliant facilities and undergo rigorous third-party mass spectrometry and HPLC purity validation strictly for in vitro and preclinical investigation.
Investigators searching for follistatin peptide kopen often navigate a landscape of varying purity levels, undisclosed formulation additives, and inconsistent batch quality. Follistatin is an autocrine glycoprotein that plays a pivotal regulatory role in cellular proliferation, differentiation, and tissue remodeling by binding specifically to members of the Transforming Growth Factor-Beta (TGF-β) superfamily. In specialized laboratory research, purchasing raw or reconstituted peptides without lot-specific analytical documentation introduces unacceptable experimental variability.
To maintain rigorous reproducibility in cellular assays and animal models, research facilities must source peptides verified through reversed-phase high-performance liquid chromatography (RP-HPLC) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS). PX1 Research provides fully documented laboratory reagents shipped directly from facilities in California and Arizona. Every lot is paired with a transparent Certificate of Analysis (COA) generated by an ISO 17025 accredited testing facility, ensuring that researchers analyzing research peptides obtain consistent, highly characterized compounds.
Follistatin exists in multiple distinct isoforms derived from alternative splicing of the *FST* gene. Understanding these structural variations is vital when selecting reagents for specific targeted assays. The primary precursor protein consists of 344 amino acids, frequently referred to as Follistatin-344. Following translation, post-translational modification and cleavage yield circulating isoforms, predominantly Follistatin-315 and Follistatin-288.
Follistatin-315 represents the major circulating form of the peptide in biological systems. It features a carboxyl-terminal domain that masks its heparin-binding region, allowing it to circulate freely in systemic circulation without immediately sequestering to cell surface proteoglycans. Conversely, shorter isoforms or full-length precursor constructs like Follistatin-315 research compounds exhibit varying binding affinities for cell-surface glycosaminoglycans. Selecting the appropriate structural form depends heavily on whether an experiment targets localized cellular receptors or systemic ligand interactions in model systems.
The primary biochemical function of Follistatin is the high-affinity neutralization of specific TGF-β superfamily ligands, most notably Activin A and Myostatin (Growth Differentiation Factor 8, or GDF-8). In vitro binding kinetics demonstrate that Follistatin forms an irreversible bivalent complex with Activin dimers, effectively preventing the ligand from engaging Activin Type II Receptors (ActRIIA/ActRIIB).
By occupying the receptor-binding epitopes of GDF-8 and Activin, Follistatin blocks downstream intracellular signaling cascades mediated by Smad2 and Smad3 transcription factors. Preclinical literature indicates that inhibiting this cascade mitigates the transcriptomic activation of ubiquitin-proteasome pathways responsible for protein degradation. Researchers evaluating myostatin inhibition mechanisms utilize Follistatin to study baseline cellular turnover, skeletal muscle hypertrophy models, and fibrotic signaling pathways in culture.
In vitro studies utilizing primary myoblast cultures demonstrate that introducing recombinant or synthetic Follistatin accelerates myotube fusion and increases cross-sectional area by suppressing endogenously secreted GDF-8. These cellular models provide key insights into satellite cell activation, microRNA expression profiles, and mitochondrial biogenesis under suppressed TGF-β signaling conditions.
In vivo rodent models have further illuminated Follistatin's functional dynamics. Experimental administration in murine models of muscle dystrophy and muscle wasting has demonstrated marked preservation of lean tissue mass and enhanced contractile force output. Furthermore, research documented in our research library highlights Follistatin’s secondary interactions with Activin B and Bone Morphogenetic Proteins (BMP-6 and BMP-7), expanding its relevance to bone density assays, hepatic tissue regeneration, and metabolic homeostasis research.
For researchers executing sensitive biological assays, peptide purity extends beyond simple peptide content. The presence of truncation sequences, residual trifluoroacetic acid (TFA) salts, or bacterial endotoxins can confound experimental readouts, trigger false immune responses in cell cultures, or induce cell toxicity. PX1 Research mandates third-party lot testing to ensure every batch meets strict purity benchmarks exceeding 98%.
RP-HPLC analysis establishes chromatographic purity by verifying the absence of closely related synthesis impurities. Concurrently, Mass Spectrometry confirms the exact molecular weight and amino acid sequence identity. Crucially, because Follistatin is frequently introduced into live cell culture or animal research models, bacterial endotoxin testing (LAL assay) is conducted to ensure levels remain well below standard institutional thresholds (<0.01 EU/μg). Facilities needing bulk quantities or custom specifications can review our wholesale lab procurement program for specialized analytical documentation.
Proper reconstitution is essential to maintain the tertiary structure and biological activity of Follistatin peptides. Lyophilized Follistatin should be reconstituted using sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream protocol. For long-term storage of reconstituted stock solutions, adding a carrier protein such as 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) prevents non-specific adsorption of the peptide to the walls of microcentrifuge tubes.
Investigators should avoid vigorous vortexing, which can introduce shear stress and induce protein aggregation or denaturation. Instead, gentle inversion or gentle swirling at room temperature is recommended until the cake is fully dissolved. Once reconstituted, stock aliquots should be prepared immediately to avoid repeated freeze-thaw cycles, which compromise the peptide's structural binding affinity.
Lyophilized Follistatin peptides are stable at room temperature for short transport intervals, but long-term preservation requires storage at -20°C or -80°C in a manual defrost freezer. Desiccated storage conditions prevent moisture absorption, which can catalyze hydrolytic degradation over extended periods.
Reconstituted liquid aliquots are stable at 2°C to 8°C for up to 7 to 14 days when formulated with appropriate antimicrobial agents or sterile buffers. For long-term storage of reconstituted solutions, working aliquots should be frozen at -80°C. Data indicates that properly stored lyophilized powder maintains structural integrity and binding capacity for up to 24 months from the date of manufacture.
When designing pathways assays targeting tissue growth or cellular protection, researchers often compare Follistatin against other modulators within the TGF-β pathway and extracellular matrix repair peptides. Follistatin acts primarily as an upstream ligand trap, neutralizing GDF-8 and Activins before they interact with membrane-bound receptors.
In contrast, experimental designs evaluating multi-pathway tissue remodeling may compare Follistatin to direct myostatin antibodies or broad-spectrum repair peptides such as BPC-157. While Follistatin uniquely regulates the ActRIIB cascade to prevent protein degradation, compounds like BPC-157 influence focal adhesion kinase (FAK) and VEGFR2 pathways to promote angiogenesis. Researchers investigating comparative protein expression profiles often utilize combinations of these distinct target classes in controlled preclinical models.
Selecting a supplier for specialized reagents requires complete transparency regarding manufacturing origin and quality assurance protocols. PX1 Research operates strictly within US-based, GMP-compliant facilities, eliminating the purity variations and supply chain disruptions common with unverified overseas distributors.
Every batch of Follistatin undergoes rigorous verification, ensuring that institutions seeking follistatin peptide kopen receive high-purity, fully traceable compounds. Orders ship same-day from distribution centers in California and Arizona, providing fast, reliable delivery for time-sensitive laboratory schedules.
What is the primary research application of Follistatin peptide?
Follistatin is used in laboratory settings to investigate the regulation of TGF-β superfamily proteins, specifically neutralization kinetics involving Activin A and Myostatin (GDF-8) in cellular growth, differentiation, and tissue degradation assays.
How does Follistatin-315 differ from Follistatin-344 in research models?
Follistatin-315 is the primary circulating isoform containing a masked heparin-binding domain, making it ideal for systemic circulating assays. Follistatin-344 is the precursor protein that is processed into shorter isoforms with variable tissue-binding characteristics.
What analytical methods are used to verify PX1 Research Follistatin purity?
Every lot undergoes Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination, Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-TOF MS) for sequence verification, and Limulus Amebocyte Lysate (LAL) testing for endotoxin levels.
How should lyophilized Follistatin be stored upon arrival?
Lyophilized Follistatin should be stored at -20°C or -80°C in a dry environment. Stored under desiccated sub-zero conditions, the compound remains stable for up to 24 months.
What is the recommended reconstitution solvent for cell culture assays?
Reconstitution in sterile PBS (pH 7.4) or sterile Bacteriostatic Water is standard. Adding a 0.1% carrier protein (such as BSA) helps prevent non-specific adsorption to container surfaces during micro-aliquoting.
What are the acceptable endotoxin limits for PX1 Research compounds?
PX1 Research enforces strict quality thresholds, ensuring endotoxin levels remain below 0.01 EU/μg to prevent inflammatory or toxic responses in cell culture and animal models.
Can Follistatin be used for human consumption or therapeutic purposes?
No. Follistatin supplied by PX1 Research is strictly designated for in vitro, non-human preclinical laboratory research use only. It is not for medical, clinical, or therapeutic applications.
Where are PX1 Research Follistatin peptides manufactured and shipped from?
All PX1 Research peptides are manufactured in US-based, GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.